Your browser doesn't support javascript.
loading
Evolution of the joint International Atomic Energy Agency (IAEA), International Agency for Research on Cancer (IARC), and WHO cancer control assessments (imPACT Reviews).
Veljkovikj, Igor; Ilbawi, André M; Roitberg, Felipe; Luciani, Silvana; Barango, Prebo; Corbex, Marilys; Dorji, Gampo; Gunawardena, Nalika; Johnson, Sonali; Juric, Arsen; Siewert, Kendall; Saporiti, Giovanni; Nobile, Marianna; Sauvaget, Catherine; Vidanapathirana, Janaki; Wright, Beverley; Lishimpi, Kennedy; Kaidarova, Dilyara; Pomata, Alicia; Malick, Anne; Dangou, Jean Marie; Abdel-Wahab, May; Weiderpass, Elisabete; Mikkelsen, Bente; Stevens, Lisa M.
Afiliación
  • Veljkovikj I; Division Programme of Action for Cancer Therapy (PACT), International Atomic Energy Agency (IAEA) Vienna, Austria. Electronic address: I.veljkovik@iaea.org.
  • Ilbawi AM; World Health Organization, Geneva, Switzerland.
  • Roitberg F; World Health Organization, Geneva, Switzerland.
  • Luciani S; Noncommunicable Diseases, Violence and Injury Prevention, Pan-American Health Organization, World Health Organization, Washington, DC, USA.
  • Barango P; Noncommunicable Diseases, Inter-country Support Team for East and Southern Africa, Regional Office for Africa, World Health Organization, Brazzaville, Republic of Congo.
  • Corbex M; Noncommunicable Diseases, Regional Office for Europe, World Health Organization, Copenhagen, Denmark.
  • Dorji G; Noncommunicable Diseases and Mental Health, Country Office Nepal, World Health Organization, Lalitpur, Nepal.
  • Gunawardena N; Noncommunicable Diseases, Country Office Sri Lanka, World Health Organization, Colombo, Sri Lanka.
  • Johnson S; Knowledge, Advocacy, and Policy, Union for International Cancer Control (UICC), Geneva, Switzerland.
  • Juric A; Division Programme of Action for Cancer Therapy (PACT), International Atomic Energy Agency (IAEA) Vienna, Austria.
  • Siewert K; Division Programme of Action for Cancer Therapy (PACT), International Atomic Energy Agency (IAEA) Vienna, Austria.
  • Saporiti G; Division Programme of Action for Cancer Therapy (PACT), International Atomic Energy Agency (IAEA) Vienna, Austria.
  • Nobile M; Division Programme of Action for Cancer Therapy (PACT), International Atomic Energy Agency (IAEA) Vienna, Austria.
  • Sauvaget C; Early Detection Prevention and Infections Branch, International Agency for Research on Cancer (IARC), Lyon, France.
  • Vidanapathirana J; National Cancer Control Programme, Ministry of Health, Colombo, Sri Lanka.
  • Wright B; Health Systems Strengthening Programme, Ministry of Health and Wellness, Kingston, Jamaica.
  • Lishimpi K; Department of Cancer Control Services, Ministry of Health, Lusaka, Zambia.
  • Kaidarova D; Kazakh Research Institute of Oncology and Radiology, Almaty, Kazakhstan.
  • Pomata A; National Cancer Control Programme, Ministry of Health, Asunción, Paraguay.
  • Malick A; Division of Noncommunicable Diseases, Ministry of Health, Dakar, Senegal.
  • Dangou JM; Noncommunicable Diseases Management, Regional Office for Africa, World Health Organization, Brazzaville, Republic of Congo.
  • Abdel-Wahab M; Division of Human Health (NAHU), International Atomic Energy Agency (IAEA) Vienna, Austria.
  • Weiderpass E; International Agency for Research on Cancer (IARC), Lyon, France.
  • Mikkelsen B; Department of Noncommunicable Diseases, World Health Organization, Geneva, Switzerland.
  • Stevens LM; Division Programme of Action for Cancer Therapy (PACT), International Atomic Energy Agency (IAEA) Vienna, Austria.
Lancet Oncol ; 23(10): e459-e468, 2022 10.
Article en En | MEDLINE | ID: mdl-36174632

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 / Neoplasias / Energía Nuclear Límite: Humans Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 / Neoplasias / Energía Nuclear Límite: Humans Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido